Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.

Mark Bigham(Canadian Blood Services), M. Leila Srour, Ray Copes(University of British Columbia)
PubMed
May 1, 2002
Cited by 17

Related Papers

The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
|Vaccine|2013|159
Thiomersal in Vaccines
|Drug Safety|2005|84
Public health and hepatitis C.
|PubMed|2000|41
Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students
|The Pediatric Infectious Disease Journal|2003|39
Hepatitis E in Canadian blood donors
|Transfusion|2017|39